Sales Agreements in the Pharmaceuticals Industry

62 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Avalo Therapeutics, Inc. Common Stock Sales Agreement with TD Securities (USA) LLC (June 5, 2025)
Sales Agreements
Cerecor Inc.
Pharmaceuticals
NY
2025
Amendment No. 1 to Sales Agreement between Whitehawk Therapeutics, Inc. and TD Securities (USA) LLC
Sales Agreements
Aerpio Pharmaceuticals, Inc.
Pharmaceuticals
NY
2025
CNS Pharmaceuticals, Inc. Common Stock Sales Agreement with A.G.P./Alliance Global Partners (July 26, 2024)
Sales Agreements
CNS Pharmaceuticals, Inc.
Pharmaceuticals
NY
2024
Sales Agreement between Edgewise Therapeutics, Inc. and Leerink Partners LLC for $175,000,000 Common Stock Offering
Sales Agreements
Edgewise Therapeutics, Inc.
Pharmaceuticals
NY
2024
Sales Agreement between Cumberland Pharmaceuticals Inc. and H.C. Wainwright & Co., LLC for Common Stock Offering
Sales Agreements
CUMBERLAND PHARMACEUTICALS INC
Pharmaceuticals
NY
2024
Sales Agreement between VYNE Therapeutics Inc. and Cowen and Company, LLC for Up to $50 Million of Common Stock
Sales Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2024
Amendment No. 1 to Sales Agreement between Avalo Therapeutics, Inc. and Oppenheimer & Co. Inc.
Sales Agreements
Cerecor Inc.
Pharmaceuticals
2023
Sales Agreement for Assets and Intellectual Property at 1270 Don's Ln, Conway, AR between Adamis Pharmaceuticals Corporation and FarmaKeio AR LLC
Sales Agreements
Adamis Pharmaceuticals Corp
Pharmaceuticals
AR
2023
Eloxx Pharmaceuticals, Inc. Sales Agreement with Oppenheimer & Co. Inc. for Common Stock Offering
Sales Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NY
2023
Sales Agreement between Terns Pharmaceuticals, Inc. and Cowen and Company, LLC for Up to $150,000,000 of Common Stock
Sales Agreements
Terns Pharmaceuticals, Inc.
Pharmaceuticals
NY
2023
Sales Agreement between Avalo Therapeutics, Inc. and Oppenheimer & Co. Inc. for At-the-Market Offering of Common Stock
Sales Agreements
Cerecor Inc.
Pharmaceuticals
NY
2023
Sales Agreement between Satsuma Pharmaceuticals, Inc. and Virtu Americas LLC for At-the-Market Offering of Common Stock
Sales Agreements
Satsuma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2022
Amendment No. 1 to Sales Agreement between Trevi Therapeutics, Inc. and SVB Securities LLC
Sales Agreements
Trevi Therapeutics, Inc.
Pharmaceuticals
NY
2022
Forward Purchase Agreement between CPHARMACEUTICA DISTRIBUIDORA DE PRODUTOS MEDICOS LTDA and Allied Corp for CBD Retail Products
Sales Agreements
COSMO VENTURES INC
Pharmaceuticals
2022
Sales Agreement between Agile Therapeutics, Inc. and H.C. Wainwright & Co., LLC for Common Stock Issuance
Sales Agreements
AGILE THERAPEUTICS INC
Pharmaceuticals
NY
2022
Assertio Holdings, Inc. $25,000,000 Common Stock Sales Agreement with Roth Capital Partners, LLC (December 17, 2021)
Sales Agreements
Assertio Holdings, Inc.
Pharmaceuticals
NY
2022
Sales Agreement between Tilray Brands, Inc. and Jefferies LLC and Canaccord Genuity LLC (March 3, 2022)
Sales Agreements
Tilray, Inc.
Pharmaceuticals
NY
2022
Eloxx Pharmaceuticals, Inc. and SVB Leerink LLC Sales Agreement for Common Stock
Sales Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NY
2021
At Market Issuance Sales Agreement between CorMedix Inc. and Truist Securities, Inc. and JMP Securities LLC, dated August 12, 2021
Sales Agreements
CorMedix Inc.
Pharmaceuticals
GA
2021
Amended and Restated At Market Issuance Sales Agreement between CorMedix Inc., B. Riley Securities, Inc., and Needham & Company, LLC dated November 27, 2020
Sales Agreements
CorMedix Inc.
Pharmaceuticals
NY
2020
Common Stock Sales Agreement between 9 Meters Biopharma, Inc. and SunTrust Robinson Humphrey, Inc.
Sales Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2020
Cultivation and Sales Agreement between MJ Holdings, Inc. and Acres Cultivation, LLC dated January 18, 2019
Sales Agreements
MJ Holdings, Inc.
Pharmaceuticals
NV
2019
Tilray, Inc. $400,000,000 Sales Agreement with Cowen and Company, LLC (September 10, 2019)
Sales Agreements
Tilray, Inc.
Pharmaceuticals
NY
2019
Sales Agreement between Axsome Therapeutics, Inc. and SVB Leerink LLC (May 9, 2019)
Sales Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
NY
2019
Common Stock Sales Agreement between Innovate Biopharmaceuticals, Inc. and H.C. Wainwright & Co., LLC and Ladenburg Thalmann & Co. Inc.
Sales Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2018
Exclusive Sales and Marketing Agreement between Eyemax LLC and Eton Pharmaceuticals, Inc.
Sales Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Amendment No. 1 to Sales/Marketing Agreement among Eton Pharmaceuticals, AL Pharma, SCS National, and Dry Creek Project
Sales Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
2018
Sales Agreement between Canbiola, Inc. and Christy Davies for CBD Product Sales
Sales Agreements
Canbiola, Inc.
Pharmaceuticals
NY
2018
Sales Representative Agreement between Cherubim Interests, LLC (dba BCS USA) and United Cannabis Corporation
Sales Agreements
United Cannabis Corp
Pharmaceuticals
2017
Sales Representative Agreement between Cherubim Interests, LLC (dba BCS USA) and United Cannabis Corporation
Sales Agreements
United Cannabis Corp
Pharmaceuticals
2017
Amendment No. 1 to Sales Contract between Horizon Pharma USA, Inc. and BASF Corporation
Sales Agreements
Horizon Pharma plc
Pharmaceuticals
2017
Sales Representative Agreement between Cherubim Interests, LLC (dba BCS USA) and United Cannabis Corporation
Sales Agreements
United Cannabis Corp
Pharmaceuticals
2017
Sales Agreement between Opexa Therapeutics, Inc. and IFS Securities, Inc. for At-the-Market Offering of Common Stock
Sales Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2016
Agreement for Sale of Paper Bags between Makkanotti Group Corp. and Epidorpio Confectionery (February 17, 2015)
Sales Agreements
Cure Pharmaceutical Holding Corp.
Pharmaceuticals
2015
Sales Agreement for At-the-Market Offering Program between Intra-Cellular Therapies, Inc. and Cowen and Company, LLC
Sales Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
NY
2015
Sales Representation Agreement between Oculus Innovative Sciences, Inc. and SLA Brands, Inc.
Sales Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2015
Amendment No. 3 to Sales Agreement between Avanir Pharmaceuticals, Inc. and Cowen and Company, LLC
Sales Agreements
AVANIR PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2014
At-the-Market Issuance Sales Agreement between Oculus Innovative Sciences, Inc. and MLV & Co. LLC (April 2, 2014)
Sales Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2014
First Amendment to Sales Agreement among Opexa Therapeutics, Brinson Patrick Securities, and Meyers Associates
Sales Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2014
Amendment No. 2 to Sales Agreement between Avanir Pharmaceuticals, Inc. and Cowen and Company, LLC (December 10, 2013)
Sales Agreements
AVANIR PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2013